Mobile

Feasibility study of hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with stage III or only pleural stage IV ovarian carcinoma in first line therapy

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-009467-59

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Feasibility study evaluating the safety of hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with stage III or only pleural stage IV ovarian carcinoma in first line therapy.

Critère d'inclusion

  • Inclusion criteria : 1. Histologically confirmed ovarian carcinoma or primary peritoneal carcinoma or Fallopian tube carcinoma. 2. FIGO stage III disease or only pleural stage IV disease 3. Age less than 65 years 4. ECOG performance status 0-1. 5. Adequate bone marrow, hepatic and renal functions. 6. No serious cardiac or respiratory illness

Liens